Jim Cramer -- 19 Companies That Could Get Acquired in 2015
|
03/23/15 - 12:35 PM EDT
Agios Pharmaceutical
(AGIO - Get Report)
Could Agios Pharmaceutical have a cure for cancer? It's a very real possibility for the the developmental-stage company with two cancer metabolism drugs in mid-stage clinical trials, according to Cramer, who thinks Celgene
(CELG)
will take a "15% stake" in it this year. Celgene will eventually "take
that stake to its ultimate measure, a 100% takeout maybe for as much as
double where this stock is, even as it is up already 300% this year," he
said.
Agios Pharma's market cap is $3.5 billion. Its stock was most recently trading at about $103.